Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 13, 2026
Why Is Factorial Energy (FAC) Stock Down -45.71% Today?

Why Is Factorial Energy (FAC) Stock Down -45.71% Today?

Key Takeaways

  • Factorial Energy shares plunged 45.71% to $5.06 in Monday trading, erasing hundreds of millions in market value from the solid-state battery developer.
  • The sell-off occurred despite a seemingly positive announcement of a strategic partnership with Netherlands-based Tulip Tech Group to deploy solid-state and lithium-metal batteries for next-generation drones.
  • Initial flight testing showed a more than 30% increase in flight range, yet the market reacted with heavy selling pressure, suggesting deeper concerns about commercialization timelines and capital needs.
  • Broader market weakness in pre-revenue, high-valuation technology stocks compounded the decline, as investors continued rotating away from speculative names with no near-term path to profitability.
  • Traders are now watching the upcoming Water Tower Research fireside chat on July 15 for any clarity on manufacturing strategy, cash runway, and partnership economics.

Opening Summary

Shares of FAC, Factorial Energy Inc., a U.S.-based solid-state battery technology company backed by Mercedes-Benz, Stellantis, Hyundai, and Kia, cratered 45.71% in Monday's trading session. The stock last changed hands at $5.06, down sharply from Friday's closing price of $9.32. The dramatic decline came on the same day the company announced a strategic partnership with Tulip Tech Group to accelerate commercial deployment of its solid-state and lithium-metal batteries for unmanned aerial vehicles. Despite early customer flight tests demonstrating a more than 30% increase in flight range, the market delivered a resounding rejection of the news, sending the stock to its lowest levels since the company's Nasdaq debut following its SPAC merger.

Partnership Announcement Fails to Inspire Confidence

The catalyst that might have been expected to lift shares instead triggered a rout. Factorial Energy and Tulip Tech, a Netherlands-based integrator of high-density battery packs for UAVs serving over 250 customers across defense, security, and commercial sectors, established a commercialization framework that includes joint customer engagement and a roadmap toward volume production. Tulip has delivered over 100,000 battery packs in a single month and counts NASA among its clients, lending credibility to the partnership.

However, the announcement contained no financial terms, no revenue commitments, and no specific timeline for volume production. For a company that has yet to report meaningful revenue and posted negative EBITDA of $34.47 million over the last twelve months, the market appeared to view the partnership as lacking the concrete commercial milestones needed to justify Factorial's elevated valuation. The absence of binding purchase orders or revenue projections likely fueled the sell-off, as investors reassessed the gap between technological promise and commercial reality.

Pre-Revenue SPAC Company Under Pressure

Factorial Energy completed its business combination with Cartesian Growth Corporation III in early June 2026, debuting on Nasdaq with an implied equity value of approximately $1.3 billion. The stock experienced extreme volatility in its first weeks of trading, surging as high as $25.33 before beginning a steady descent. As a pre-revenue company with no established commercial product sales, Factorial remains highly vulnerable to shifts in risk appetite across the broader market.

The company's most recent financial disclosures revealed a net loss of $69.55 million, negative free cash flow of $31.59 million, and a cash position of $25.45 million against $33.11 million in debt. With a current ratio of 5.50, the company is not facing an immediate liquidity crisis, but the path to self-sustaining operations remains uncertain. The market's reaction to the Tulip partnership suggests growing impatience with capital-intensive technology companies that have yet to convert laboratory and testing milestones into revenue-generating contracts.

Broader Market and Sector Context

The sell-off in FAC did not occur in isolation. Pre-revenue technology companies, particularly those that entered public markets via SPAC mergers, have faced intensifying scrutiny as investors demand clearer paths to profitability. The solid-state battery sector, while promising enormous long-term potential, remains years away from mass commercial adoption in automotive and aerospace applications. Factorial's own CEO, Dr. Siyu Huang, has emphasized a capital-light manufacturing strategy, but the market appears skeptical that this approach can deliver the scale needed to compete with well-funded rivals.

Trading volume in FAC was exceptionally heavy, running at more than seven times the average daily volume, indicating significant institutional repositioning. The stock sliced through its 50-day moving average of $11.82 and its 200-day moving average of $10.60, triggering additional technical selling as momentum-focused traders exited positions.

Trending AI Robots

In volatile market environments like the one impacting FAC today, traders increasingly turn to algorithmic strategies to navigate rapid price swings. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers across multiple strategies, timeframes, and performance metrics, only the top performers are showcased in this dynamic, real-time selection. Each bot varies by its trading approach, from swing trading to long-term trend following, allowing users to identify strategies aligned with their risk tolerance and market outlook. Explore the Trending AI Robots page to discover which automated strategies are currently outperforming.

What Comes Next for FAC

Factorial Energy faces a critical test of investor confidence in the days ahead. The company's CEO is scheduled to participate in a Water Tower Research fireside chat on July 15, providing management an opportunity to address the market's concerns directly. Investors will be listening closely for any quantification of the Tulip partnership's revenue potential, updates on the company's cash position and funding requirements, and clarity on the timeline for converting technological milestones into commercial contracts.

The company's next earnings report is expected around August 15, which will provide updated financials and potentially the first glimpse of any revenue generation. Key risks include the possibility of future equity dilution if the company needs to raise additional capital, execution risk in scaling manufacturing, and the inherent uncertainty of commercializing next-generation battery technology in competitive aerospace and automotive markets. For now, the stock's direction will likely be dictated by whether management can convince the market that the Tulip partnership represents a genuine inflection point rather than another early-stage collaboration with an uncertain payoff.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FAC

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


FAC in +11.86% Uptrend, advancing for three consecutive days on August 03, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FAC advanced for three days, in of 26 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FAC's RSI Indicator exited the oversold zone, of 3 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on FAC as a result. In of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FAC just turned positive on July 30, 2026. Looking at past instances where FAC's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .

FAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (8.012). P/E Ratio (0.000) is within average values for comparable stocks, (124.144). FAC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.366). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (9.854).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.87B. The market cap for tickers in the group ranges from 457 to 300.34B. CYATY holds the highest valuation in this group at 300.34B. The lowest valued company is NXUR at 457.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was 2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -2%. CBAT experienced the highest price growth at 59%, while ELPW experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 31% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 71
Price Growth Rating: 61
SMR Rating: 84
Profit Risk Rating: 83
Seasonality Score: -15 (-100 ... +100)
View a ticker or compare two or three
FAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages providing personal automobile insurance services and other related products

Industry ElectricalProducts

Profile
Details
Industry
Property Or Casualty Insurance
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.